Relationship among somatostatin, neuron-specific enolase and early vascular dementia
10.3969/j.issn.1008-0074.2017.02.11
- VernacularTitle:生长抑素、神经元特异性烯醇化酶与早期血管性痴呆的关系
- Author:
Zhigang YANG
;
Lingling ZHANG
;
Xiang LI
;
Renkai LIU
;
Jinling HAN
;
Chunshui YANG
- Keywords:
Somatostatin;
Phosphopyruvate hydratase;
Dementia;
vascular
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2017;26(2):159-162
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the relationship among somatostatin (SS), neuron-specific enolase (NSE) and early vascular dementia.Methods: A total of 40 patients with early vascular dementia treated in our hospital were selected as vascular dementia group, another 40 inpatients with cerebral infarction (CI) treated during the same period were enrolled as CI group.Plasma NSE and SS levels were compared between two groups during different periods.Results: Compared with CI group at onset, one month and three months after CI, there was significant rise in plasma NSE level[(22.08±7.05) ng/ml vs.(26.39±6.80) ng/ml, (23.92±4.25) ng/ml vs.(28.12±4.06) ng/ml, (25.55±4.72) ng/ml vs.(30.10±4.33) ng/ml], and significant reduction in plasma SS level[(1084.50±133.00) ng/ml vs.(748.30±129.10) ng/ml, (836.40±160.20) ng/ml vs.(624.25±140.50) ng/ml, (690.25±146.30) ng/ml vs.(432.70±151.00) ng/ml]in vascular dementia group, P<0.05 or <0.01.Plasma NSE level gradually rose and SS level gradually reduced along with the time went by(P<0.05 or <0.01).Conclusion: Early dynamic detection of somatostatin and neuron-specific enolase levels in patients with cerebral infarction may help to early diagnosing and treatment of vascular dementia.
